SEC 13F Intelligence

Atlas Venture Associates Ix, LLC / CHRS

Atlas Venture Associates Ix, LLC’s Coherus Oncology Inc Position

Does Atlas Venture Associates Ix, LLC own Coherus Oncology Inc (CHRS)? Yes568.4K shares worth $2M (+18.08% of its 13F portfolio) as of Q3 2023.

Position Value
$2M
Q3 2023
Shares
568.4K
% of Portfolio
+18.08%
Quarters Held
1
currently held

Position History CHRS

Reported value by quarter
Q3 ’23: $2MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023568.4K$2M+18.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Associates Ix, LLC’s full portfolio or all institutional holders of CHRS.